Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Mesenchymal Stem Cells in Multiple System Atrophy
NCT00911365Phase 2Completed
- Sponsor
- Yonsei University
- Start
- May 2008
- Primary completion
- Jun 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in multiple system atrophy (MSA), sponsored by Yonsei University. Started May 2008; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT00911365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911365.